Innophos Holdings, Inc. provided earnings guidance for the full year 2019. The Company is reducing its revenue expectations. Revenues are now expected to be 1% to 2% below 2018 revenue of $802 million. This revised range reflects the impact from the softer demand the Company began to experience in First Quarter in certain industrial categories. The Company expects the order pattern and Midwest flooding timing delays experienced in the first quarter to rebound over the next two quarters. Additionally, Innophos continues to expect positive year-over-year revenue contribution from price increases and new product wins to be offset by the discontinuation of lower-margin FHN nutrition trading business in 2018, lower co-product sales in the Other segment due to efficiency improvements, and indirect tariffs pressure from competition redirecting mostly technical grade product to international markets.